April 2014 FDA Recall Drug by Wockhardt Usa Inc.
D-0304-2015 - Failed Dissolution Specifications
This Class III drug recall was voluntarily initiated by Wockhardt Usa Inc. on April 17, 2014 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0304-2015
Failed Dissolution Specifications: Product was out of specification (OOS) at the 12 month long term stability testing point.
04-17-2014
12-24-2014
1,118,400 extended release tablets
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Wockhardt Usa Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide.
08-13-2015
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Wockhardt Metoprolol Succinate, Extended-Release Tablets USP, 50 mg, a)100-count HDPE bottle (NDC 64679-735-02), b) 4000-count pack (64679-735-08), Manufactured by: Wockhardt Limited, Mumbai, India Distributed by Wockhardt USA LLC. 20 Waterview Blvd. Parsippany, NJ 07054 USA .
Batch or Lot Expiration Information
Lot# a)
Lot# LN10392; Exp. 12/14 b)
Lot# LN10360; Exp. 12/14